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Electron transferIn this mini review, we brieﬂy survey the molecular processes that lead to reactive oxygen species (ROS) pro-
duction by the respiratory complex III (CIII or cytochrome bc1). In particular, we discuss the “forward” and
“reverse” electron transfer pathways that lead to superoxide generation at the quinol oxidation (Qo) site of
CIII, and the components that affect these reactions. We then describe and compare the properties of a bac-
terial (Rhodobacter capsulatus) mutant enzyme producing ROS with its mitochondrial (human cybrids) coun-
terpart associated with a disease. The mutation under study is located at a highly conserved tyrosine residue
of cytochrome b (Y302C in R. capsulatus and Y278C in human mitochondria) that is at the heart of the quinol
oxidation (Qo) site of CIII. Similarities of the major ﬁndings of bacterial and human mitochondrial cases, in-
cluding decreased catalytic activity of CIII, enhanced ROS production and ensuing cellular responses and
damages, are remarkable. This case illustrates the usefulness of undertaking parallel and complementary
studies using biologically different yet evolutionarily related systems, such as α-proteobacteria and human
mitochondria. It progresses our understanding of CIII mechanism of function and ROS production, and under-
lines the possible importance of supra-molecular organization of bacterial and mitochondrial respiratory
chains (i.e., respirasomes) and their potential disease-associated protective roles. This article is part of a
Special Issue entitled: Respiratory complex III and related bc complexes.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
1.1. Reactive oxygen species
Reactive oxygen species (ROS) are a group of radical or non-radical
oxygen containing molecules that display high reactivity with lipids,
proteins and nucleic acids. Depending on the concentration, location,
andmolecular context, ROS can be beneﬁcial or harmful to cells. Increas-
ing evidence indicates that homeostatic and physiological levels of ROS
are indispensable in regulating diverse cellular processes, including ion
channel/transporter function [1], Ca2+ spark production [2,3], protein
kinase/phosphatase activation and gene expression [4]. A current view
is that low levels of ROS production contribute to many essential intra-
cellular signaling processes ranging from cell metabolism to ischemia
preconditioning in eukaryotic cells [4–6]. Conversely, excessive ROS
generation often leads to apoptotic and necrotic cell death [7,8] as wellron transport chain; O2•-, super-
ical; H2O2, hydrogen peroxide;
, complex III (cytochrome bc1),
dismutase
tory complex III and related bc
+1 215 898 8780.
l rights reserved.as to a panel of clinically distinct disorders, including neurodegeneration
(e.g., Alzheimer's disease), cardiomyopathies, diabetes and cancer
[9–11]. Accumulative and systemic ROS damages also underlie cell se-
nescence and aging [6,12].
In quiescent cells, ROS are primarily produced as byproducts of
mitochondrial respiration when electrons leak from the electron
transport chain (ETC) (Fig. 1) [13]. Superoxide anions (O2•-) are the
primary ROS species generated by the ETC, and are converted to hy-
drogen peroxide (H2O2) either spontaneously or by the superoxide
dismutase (SOD). In the presence of transition metals, O2•- can also
be transformed into hydroxyl radicals (•OH) that are considered to
be more reactive and damaging. Recent studies documented that
massive increases in localized ROS production could occur during
metabolic stress [6,14] and photostimulation [15]. Besides, excessive
amounts of intracellular ROS ultimately contribute to necrotic or apo-
ptotic cell death [16,17].
1.2. Oxidized and reduced quinones
Quinone molecules (oxidized Q/reduced QH2) play a central role in
O2•- generation because they act as direct electron donors/acceptors,
or redox mediators, to reduce molecular oxygen (O2). They are present
in energy transducing membranes in large amounts as compared with
other components of the respiratory chain, and serve as intermediates
Fig. 1. Structures of CI, CIII and CIV complexes of respiratory ETC and ROS production. Overall structures of individual respiratory complexes CI (PDB 3IAM + 3M9C in red and blue
for membrane integral and membrane external parts, respectively), CIII (PDB 1PP9 in green for the two monomers) and CIV (PDB 1OCC in yellow) are shown together with the Q
pool and the electron carrier cytochrome c in purple. In CIII the iron sulfur clusters are positioned in the stigmatellin-bound form and depicted as yellow and orange balls. All heme
cofactors are shown in white, red, and blue balls, except in the case of the electron carrier cytochrome c where heme is shown in red. The Q pool (made of oxidized Q and reduced
QH2) is indicated in black. The electron transfer and the proton uptake/release pathways are shown in red and blue arrows, respectively. The CI and CIII complexes of the mitochon-
drial respiratory ETC are generally considered to be the main sources of O2•- radicals, indicated with thick dark blue arrows. In CI, O2•- is thought to be produced primarily at the
FMN (ﬂavine mononucleotide) cofactor facing the matrix side, whereas in CIII2 it is generated at the ubiquinol oxidation site (Qo site) facing the inter membrane space of
mitochondria.
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(Fig. 1). The redox chemistry of Q/QH2 is reversible, fast, and involves
two consecutive “one-electron” reduction steps via a semiquinone radi-
cal (SQ•-) intermediate. While this property of Q/QH2 is important dur-
ing energy transduction to store reducing equivalents, it also constitutes
a liability for ROS generation, especiallywhenQ/QH2 catalysis is notwell
conﬁned to speciﬁc niches in related proteins. This process is often re-
ferred to as the ‘leakage of electrons’ from the ETC complexes [18]. In ad-
dition to their redox functions, QH2 molecules can also reduce O2 via a
“one-electron” reduction step leading to the formation of O2•-, which
is the main source of ROS in cells. However, direct oxidation of QH2 by
O2 is slow and spin-forbidden, whereas the redox reactions between
SQ•- andO2 ultimately yieldingO2•- can be very fast [19]. These reactions
strongly depend on howwell SQ•- binds to its site of generation aswell as
the redoxpotential of theQ/SQ•- couple, thus on the stability constant and
the local factors modulating its disproportionation [20]. As O2 partitions
favorably into the lipid phase, co-partitioning would allow O2 and SQ•-
to react effectively unless the latter species is sequestered away from
accessing O2. The local concentration and stability of SQ•- have been opti-
mized during evolution in the case of the ETC complexes that perform Q/
QH2 redox chemistry. It is also noteworthy that the reaction leading to
O2•- production is reversible, which allows Q to be used as a protective
agent against oxidative damages by consuming O2•- radicals [21,22].
1.3. Production of ROS by ETC
Although still subject to controversy, it is believed that ROS are
produced in the cell mainly during perturbations of respiratory
chain functions [6]. Increased supply of electrons to ETC, (e.g., excess
of reducing equivalents) or enhancedmembrane potential generation
leads to an increase of SQ•- content in membranes, and subsequently,
to higher O2•- production. Moreover, kinetic constraints exerted
downstream of the Q pool (e.g., blocking electron ﬂow at the level
of cytochrome c oxidase, CIV) further enhance production of SQ•-.
Conversely, moderate uncoupling of the membrane potential de-
creases the electron ﬂux constraints across ETC, therefore decreasing
O2•- production by the respiratory complexes (Fig. 1) [23]. Both ofthese effects can also be observed upon modiﬁcation of the respirato-
ry chain by speciﬁc chemicals [24,25]. For example, free fatty acids
exert different effects on mitochondria in respect to ROS generation;
they inhibit electron ﬂux through the complex I (CI), and probably
the complex III (CIII), by inducing an increase of ROS production as
seen in isolated rat heart or liver mitochondria [26]. Fatty acids also
induce an uncoupling effect, which seems responsible for a large de-
crease in ROS formation. Thus, ROS production is ﬁne-tuned in re-
sponse to changes in electron ﬂux through ETC.
The respiratory complexes CI and CIII were well known for some
time to be involved directly in superoxide production (Fig. 1). More
recently, complex II (CII) is also implicated in this process as well
[27,28]. It has been suggested that about 2–5% of O2 consumed
might lead to O2•- generation, of which roughly 70–80% is linked to
the mechanism of function of CIII [29] based on quantitative data
obtained using isolated mitochondria. However, O2•- production
measurements depend on cell types, respiration states, materials
and techniques used to quantify the chemical free radicals. More con-
servative predictions estimate that O2•- production by ETC is perhaps
only 0.1% of physiological respiratory rates [30,31].
2. Complex III (CIII or cytochrome bc1)
2.1. Structure and mechanism of function of CIII
CIII is a major multi-subunit, membrane-bound enzyme that is
central to respiratory energy transduction pathways in many organisms
[32]. In different species, it enzymatically converts various derivatives of
QH2 to Q, and reduces various mobile or membrane-anchored electron
carriers, typically c-type cytochromes. CIII operates via the Q-cycle
mechanism, and contributes to the formation of both themembrane po-
tential and the proton gradient used for ATP production by ATP synthase
(complex V or CV) [33–35]. Depending on the species, mitochondrial CIII
contains up to eleven subunits, of which eight are not essential for enzy-
matic activity (referred to as the “supernumerary subunits”). These sub-
units are absent in most bacterial CIII, which usually contain only three
subunits as the essential catalytic core of the enzyme (Fig. 2a). Due to
Fig. 2. Structure of CIII (cytochrome bc1) and location of the conserved Tyr 302/278 of cytochrome b. a, The three dimensional structure of bacterial dimeric CIII bound with
stigmatellin that mimics QH2 (PDB 1ZRT) is shown. The catalytic subunits cytochrome b, cytochrome c1 and the Fe/S protein are shown in blue, green and purple, respectively.
Hemes are shown in yellow sticks, the [2Fe–2S] cluster in yellow and orange spheres, and the Qo site inhibitor stigmatellin in red sticks. b, Close-up views of bacterial (R. capsulatus,
PDB 1ZRT), bovine (PDB 2A06) and yeast (PDB 3CX5) mitochondrial CIII Qo site structures. The four conserved cysteine residues of the Fe/S protein (yellow and white sticks, R.
capsulatus numbering Cys 133 and Cys 153 acting as ligands of the [2Fe–2S] cluster and Cys 138 and Cys 155 forming a disulﬁde bond) are shown together with the conserved
Tyr 302/278/279 of cytochrome b substituted with Cys (gray stick, R. capsulatus Y302 → C, bovine Y278C and yeast 279). In the yeast case, the Cys342 is also indicated. c, Sequence
alignment of R. capsulatus cytochrome b residues around the conserved tyrosine 302 (278 in human and bovine, 268 in Plasmodium and 279 in yeast) and the conserved PEWYmotif
shown in red, and green, respectively. Human, bovine, yeast, Plasmodium and R. capsulatus refer to Homo sapiens (NCBI protein database accession no: P00156), Bos taurus (P00157),
Saccharomyces cerevisiae (P00163), Plasmodium yoelii (AAC25924), and Rhodobacter capsulatus (P08502) cytochrome bc1, respectively.
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structures, the facultative phototrophic bacteria (Rhodobacter capsulatus
and Rhodobacter sphaeroides) and Paracoccus denitriﬁcans are widely
used organisms as CIII models for their mitochondrial counterparts
[36–38]. The three universally conserved catalytic subunits of CIII are
the cytochrome b, the Fe/S (also called the Rieske) protein and the cyto-
chrome c1. Cytochrome b is an integral membrane protein, whereas the
Fe/S protein and cytochrome c1 are membrane-anchored by their
amino- and carboxyl-terminal helices, respectively. These three subunits
carry speciﬁc cofactors that are required for the catalytic activity of the
enzyme. These cofactors are two b-type hemes (axially coordinated
protophorphyrin IX-iron) with one low (bL) and one high (bH) Em of cy-
tochrome b, the [2Fe–2S] cluster with a high redox midpoint potential
(Em) of the Fe/S protein, and a high Em c-type heme (covalently bound
protophorphyrin IX-iron) of cytochrome c1 (Fig. 2a). Most bacterial and
mitochondrial puriﬁed CIII form dimers, and their three-dimensional
structures depict these proteins as symmetrical homodimers [36–42].
In the case of R. capsulatus CIII, monomeric forms of the enzyme are nei-
ther active nor stable. However, tetrameric forms of bacterial CIII have
been reported in at least two instances. In R. capsulatus, upon fusion of
cytochrome c1 with its physiological electron carrier cytochrome cy, for-
mation of active CIII tetramers was observed [43]. The P. denitriﬁcans na-
tive enzyme forms tetramers, but elimination of a naturally present
amino-terminal extension of cytochrome c1was reported to yield dimer-
ic CIII [36].
Each monomer of the bacterial enzyme contains the three catalytic
subunits in an unusual organization. Cytochrome bwith its eight trans-
membrane helices forms the membrane-embedded core to which the
other two subunits are bound. Facing the lipid layer on cytochrome b,
two Q/QH2 binding (QH2 oxidation (Qo) and Q reduction (Qi)) sites
are located on the positive (p) and negative (n) sides of the membrane.
The carboxyl-terminal helix of cytochrome c1 interacts closely with the
ﬁfth helix of cytochrome b to form a cytochrome b-c1 core, which inter-
acts with the mobile head domain of the Fe/S protein, leaving its amino
terminal membrane helix (i.e., tail) associated with cytochrome b of the
other monomer. In agreement with this organization, a stable dimeric
cytochrome b-c1 subcomplex has been puriﬁed from R. capsulatus.
Reconstitution of this subcomplex into an active enzyme was achievedwhen a full-length Fe/S protein was used, but not with a truncated
Fe/S protein lacking its amino-terminal tail domain [44]. The mo-
bility of the Fe/S protein head domain between cytochrome b
and cytochrome c1 and its [2Fe–2S] cluster is essential for CIII ac-
tivity [45,46].
According to the proton-motive Q-cycle mechanism, upon the dif-
fusion of a QH2 molecule from the Q-pool to the Qo site of CIII, the ox-
idized [2Fe–2S] cluster of the Fe/S protein oxidizes this QH2 and
conveys a single electron via its mobile head domain to the oxidized
cytochrome c1. This electron is then transferred down the ETC to a
terminal oxidase (e.g., CIV). The highly unstable SQ•- radical thus pro-
duced at the Qo site gives an electron to heme bL of cytochrome b,
which rapidly transfers it to heme bH across the lipid bilayer, to gen-
erate membrane potential and a stable SQ•- at the Qi site. Completion
of the catalytic turnover of CIII involves a second QH2 oxidation at the
Qo site of the dimeric CIII, via the same sequence of events described
above, converting SQ•- at the Qi site to a QH2 to be released from the
enzyme. The Qo and Qi sites of CIII are not identical with respect to
their ability to interact with the SQ•- species. While the SQ•- at the
Qi site is well characterized by EPR spectroscopy [47–49], SQ•- at
the Qo site is a subject of controversy. It is difﬁcult to detect the latter
species experimentally, and it was only seen under speciﬁc conditions
at extremely low amounts [50,51]. Moreover, no structural informa-
tion is yet available about the exact position of Q/QH2 at the Qo site.
Thus, detailed descriptions of the events that follow QH2 oxidation
by the [2Fe–2S] cluster of the Fe/S protein until the transfer of the sec-
ond electron to heme bL of cytochrome b remain unknown.
2.2. Superoxide production at the Qo site
Importance of the structural integrity of bacterial CIII for maximal
rate of catalysis and minimal rate of electron leakage to O2 is known.
Heat-inactivated or proteinase K-digested CIII [52], and catalytically
impaired mutants producing higher amounts of O2•- [53,54] have
been reported. Bifurcated electron transfer from QH2 to the [2Fe–2S]
cluster of the Fe/S protein and to the heme bL of cytochrome b at
the Qo site infers that either preventing the formation of a SQ•-, or
entrapping it within CIII to avoid its interaction with O2, should
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should enhance O2•- production as analyzed in detail by Oscyzka et
al., [18,53,54]. Two different situations lead to SQ•- generation: a
semiforward electron pathway that produces a SQ•- following oxida-
tion of QH2 by the Fe/S protein [20,50,51,53–57], and a semireverse
electron transfer pathway that involves electron transfer from re-
duced heme bL of cytochrome b to a Q bound at the Qo site to yield
a SQ•- (referred to as “forward” and “reverse” for simplicity) (Fig. 1)
[53,54,58,59].
2.2.1. Forward electron transfer for SQ•- generation at the Qo site of CIII
Earlier studies focused mainly on the production of O2•- at the Qo
site via the forward electron transfer pathway [20,50,51,55–57]. His-
torically, the pioneering work of Chance proposed that the residual
cytochrome c reduction activity seen when CIII is inhibited with
antimycin A was closely associated with O2•- production [60,61]. Ac-
cordingly, both electrons from QH2 oxidation would be transferred
to the electron carrier cytochrome c, but via two disparate pathways.
One electron would be delivered to cytochrome c via the high-
potential chain (i.e., the Fe/S protein and cytochrome c1), while the
other electron would be conveyed to O2 to yield O2•- which would
rapidly oxidize cytochrome c. Later on, occurrence of this process
was supported by the fact that chemical destruction of the [2Fe–2S]
cluster of the Fe/S protein [62] or maintenance of this cluster in a re-
duced state [20] inhibited O2•- formation. Similarly, inhibiting reduc-
tion of Q at the Qi site (e.g., using antimycin A) signiﬁcantly increased
Qo site mediated O2•- production. Studies of the effects of speciﬁc Qo
and Qi site inhibitors on O2•- production described the complementa-
ry bypass reactions in details [20]. For instance, decreasing the rate of
electron transfer between the hemes bL and bH of cytochrome b, or
abolishing the subsequent oxidation of these hemes via the Qi site
inhibitor antimycin A, resulted in the accumulation of electrons on
cytochrome b [18]. This led to the accumulation of SQ•- at the Qo
site and to the leak of electrons to O2 to generate O2•- [20]. In general,
if a SQ•- is formed at the Qo site (i.e., via a non concerted electron bi-
furcation) during the normal turnover of a native CIII, O2•- production
is expected to be quite low to minimize electron leakage and energy
waste. However, O2•- production at the Qo site might become signiﬁ-
cant under compromising conditions, such as a highly reduced Q pool,
presence of antimycin A-like molecules inhibiting oxidation of re-
duced b hemes of cytochrome b, extremely high membrane potential,
or speciﬁc Qo site mutations (see Section 3). Such conditions may
occur in damaged CIII enzymes, or under extreme physiological situ-
ations (e.g., ischemia and reperfusion) [63,64].
Recently, a variant of the forward electron transfer pathway was
proposed for R. sphaeroides CIII. In contrast to the earlier studies,
this model postulated that under physiological conditions, O2•- pro-
duction is not the result of a bypass reaction during the Q-cycle, but
is a regulatory step for enhancing Qo site catalysis [52,65]. The authors
entertained the idea that O2 might act as a redox mediator during
oxidation of QH2 and reduction of heme bL of cytochrome b. Accord-
ingly, O2•- formation and CIII activity would increase together as a
function of O2 concentration available during the assay conditions.
However, the relevance and validity of the relatively mild effects
(b2 fold) observed on enzyme activity require additional investiga-
tions [65].
2.2.2. Reverse electron transfer for SQ•- generation at the Qo site of CIII
In recent years, several studies focused on the bypass reactions of
the Q-cycle yielding O2•- production via a reverse electron transfer
pathway. It appears that partial oxidation of the Q pool in a physiolog-
ically relevant scenario signiﬁcantly increases the rates of O2•- pro-
duction by antimycin A inhibited CIII [58]. Using submitochondrial
particles, Dröse and Brandt observed that CIII mediated ROS produc-
tion was higher when CII activity was partially inhibited by malonate
(or oxaloacetate), linking the Q pool redox state to O2•- productionvia the Qo site of CIII. They proposed that the O2•- thus generated
was produced at the Qo site by reverse electron transfer from reduced
heme bL of cytochrome b to O2 via a SQ•- intermediate acting as a
redox mediator. Quinlan et al. further supported this proposal show-
ing that this effect might be directly driven by the redox state of
hemes bL and bH of cytochrome b that are sensitive to the Q pool
redox state and membrane potential [59]. Additional studies using
bacterial CIII mutants indicated that O2•- production at the Qo site
also involved reverse electron transfer from reduced heme bL of cyto-
chrome b, and Osyczka's group proposed a “kinetic”mechanism to ac-
count for its occurrence [54]. Accordingly, the movement of the Fe/S
protein [2Fe–2S] cluster from the Qo site increased O2•- generation,
whereas its stagnation at the Qo site decreased it. This observation
correlated the production of ROS with the position of the Fe/S protein
head domain on cytochrome b. Assuming that the movement of the
reduced Fe/S protein is not obligatorily “concerted” with electron
transfer from SQ•- to cytochrome bL heme, ROS generation could be
rationalized as the result of a kinetic competition between the inter-
nal reactions involving the cofactors of CIII, the Q residing at the Qo
site, and the reaction of SQ•- with O2 [54].3. Defective CIII catalysis and enhanced ROS production due to
speciﬁc mutations
3.1. Bacterial CIII mutations and ROS production
Studies using bacterial CIII also highlighted some speciﬁc amino
acid residues as key contributors for affecting ROS production. For
instance, the M183K or M183L substitutions in R. capsulatus cyto-
chrome c1 drastically decreased the Em of heme c1, severely impeding
electron ﬂow kinetics through the high potential chain of CIII, and en-
hancing O2•- production during Qo site catalysis [54]. In a recent study,
Lee et al. described a different role played by some amino acid residues
of cytochrome b in controlling O2•- production via the Qo site of the
bacterial CIII [66] (Fig. 2b). In R. capsulatus, substitution of the con-
served Y302 of cytochrome b with any other amino acid residue de-
creased CIII activity. Concomitantly, it increased O2•- production
independently of antimycin A inhibition or other treatments known
to enhance this process [66]. These ﬁndings indicated that some cyto-
chrome b residues are critical for suppressing ROS production at the
Qo site of the enzyme. Various structures have depicted this tyrosine
side chain in slightly different H-bonding patterns, depending on the
position of the Fe/S protein head domain and the occupant of the Qo
site [67]. Moreover, the hydroxyl group of this residue is within
H-bonding distance from a cluster of H2Omolecules in a high resolution
structure [68]. Although it is unclear how Y302X (X being any amino
acid) mutations enhance mechanistically O2•- production, the ﬁnding
that even the Y302F substitution increases O2•- production suggests
that it may be linked to the loss of the ﬁxed H2O cluster coordinated
in the native enzyme by the hydroxyl group of Y302 [66]. Accordingly,
any mutant losing the hydroxyl group would exhibit decreased CIII ac-
tivity due to the incorrect positioning of the Fe/S protein head domain.
Concomitantly, it would also produce increased O2•- due to the
uncoordinated mobility of the Fe/S protein head domain vis-a-vis the
electron transfer from SQ•- to cytochrome bL, and the ensuing undesir-
able electron leakage to O2 during Qo site catalysis.
The counterparts of R. capsulatus Y302 in other species, in particu-
lar the malarial (Y268) [69,70], yeast (Y279) [71–73] and human
(Y278C) mitochondrial mutants [74,75] were also studied with re-
spect to decreased CIII catalysis and enhanced ROS production. De-
creased CIII activities were reported for all mutants, and enhanced
O2•- production was described for several yeast and human mutants
(see below). The overall ﬁndings indicate that a number of amino
acid residues of cytochrome b at the Qo site affect both CIII catalysis
and ROS production. Whether or not all catalytically defective Qo
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the CIII enzyme, is unknown.
3.2. Bacterial cytochrome b Y302C mutation forms an inter subunit
disulﬁde bond
The bacterial mutant carrying the cytochrome b Y302C mutation
was studied in detail [66]. This mutant supported CIII-dependent
anoxygenic photosynthetic growth of R. capsulatus. However, it pro-
gressively lost its CIII activity upon exposure to air due to slow oxida-
tive disintegration of the [2Fe–2S] cluster in its Fe/S protein both
in chromatophore membranes and in puriﬁed samples [66]. On the
other hand, although the homologous yeast cytochrome b Y279C mu-
tant also produced ROS [73], its Fe/S protein [2Fe–2S] cluster did not
exhibit oxidative damage [71,73]. In the case of R. capsulatus, oxida-
tive disintegration of the [2Fe–2S] cluster required not only the pres-
ence of O2, but also the catalytic activity of the Qo site and the
presence of a free thiol group at position 302. Strict anaerobiosis,
highly reducing conditions, as well as use of Qo site inhibitor
stigmatellin or thiol-alkylating reagents (e.g., iodoacetamide or
N-ethyl-maleimide) abolished the oxidative damages in the Y302C
mutant [66]. Using the bacterial mutant CIII, mass spectrometry anal-
yses revealed for the ﬁrst time that the mutant cytochrome b and the
Fe/S protein subunits of CIII were covalently cross-linked to each
other by an inter subunit disulﬁde bond formed between the thiol
groups of cytochrome b Y302C and the Fe/S protein C155. It was
therefore proposed that the ROS-induced cysteine redox chemistry
reduced the intra molecular disulﬁde bridge, which is naturally pres-
ent in the Fe/S protein and stabilizes its [2Fe–2S], to render this clus-
ter oxygen labile and the mutant CIII air-sensitive (Fig. 2b) [66].
The striking difference seen in respect to the stability of their Fe/S
protein [2Fe–2S] clusters between the bacterial Y302C and its yeast
counterpart Y279C is intriguing. Comparison of R. capsulatus and
S. cerevisiae cytochrome b amino acid sequences show that while
the yeast protein has several cysteine residues, the bacterial counter-
part has none. In the former species, one of these cysteine residues
(C342, yeast numbering) is structurally located nearby the Y279
(Fig. 2b). Whether the presence of additional cysteine residues coun-
teracts the effect of Y279C mutation (for example by promoting an
intra molecular disulﬁde bond within cytochrome b) is unknown.
Mass spectrometry analyses of puriﬁed native, Y279F and Y279C
yeast CIII enzymes were conducted in our group. In the case of
Y279C mutant, the data indicated that the trypsin-gluC fragment
encompassing Y279 (W273YLLPFX279AILR283, where X279 is Y, F or C
in native, Y279F and Y279C mutants, respectively) is only detectable
after dithiothreitol (DTT) reduction and iodoacetamide alkylation
(unpublished data). This ﬁnding suggests that in the yeast mutant
the cysteine residue at position 279 might also be modiﬁed by a
DTT-cleavable chemical group of unknown identity. Inspection of
the bovine (Fig. 2b) and also human cytochrome b sequence indicates
that, although they also contain several cysteine residues, none of
them is structurally located in the vicinity of Y278 (homologue of R.
capsulatus Y302). Whether the oxidative disintegration of the Fe/S
protein [2Fe–2S] observed with the bacterial CIII also occurs in mam-
malian CIII remains to be seen.
3.3. Human mitochondrial cytochrome b Y278C mutation and ROS
production
Very recently, a human mitochondrial CIII produced by a
homoplasmic cybrid line generated using ﬁbroblasts of a patient
bearing the m.15579A > G (p.Y278C, i.e., the human homologue of
R. capsulatus cytochrome b Y302C mutation) (Fig. 2c) heteroplasmic
mutation became available [74,75]. Thismutationwas identiﬁed in a pa-
tient with severe exercise intolerance and multisystem disorders [76],
and provided a unique opportunity to extend the signiﬁcance of theﬁndings emanating from the bacterial case. Comparison of appropriate
homoplasmic cybrids carrying either the wild type or the cytochrome
b Y278C mutation showed increased intolerance to galactose (hallmark
of defective oxidative phosphorylation), drastic loss of CIII activity (over
~90%) and highly decreased CIII-dependent oxidative phosphorylation
in the mutant [75]. However, the enzymatic activities of the individual
CI and CII complexes, as well as the coupled activities of the CI + III
and CII + III supercomplexes were little affected in the mutant. More-
over, no complete loss of the ETC driven membrane potential, or ATP
synthesis was observed, suggesting that CI and CII were able to sustain
some ATP production despite the low CIII activity. Excitingly, as ob-
served with the bacterial CIII, enhanced O2•- production was seen inmi-
tochondria isolated from mutant cybrids, compared to wild type cells.
Moreover, an imbalance in homeostasis of the major intracellular anti-
oxidant (i.e., an increase of the ratio of oxidized (GSSG) versus reduced
(GSH) glutathione) was observed, in agreement with increased oxida-
tive stress in mutant cybrids [75]. Indeed, the CI, CIII and CI + III activi-
ties increased signiﬁcantly when mitochondrial preparations were
carried out in the presence of DTT. Due to material limitations, reliable
detection of the Fe/S protein [2Fe–2S] cluster by EPR spectroscopy has
not yet been achieved even with mitochondria from wild type human
cybrids, leaving open the question of oxidative disintegration of the
Fe/S protein [2Fe–2S] cluster via ROS production.
Similar to the bacterial case, no subunit assembly defect of CIII was
seen with the human cytochrome b Y278C mutation as compared to
wild type cybrids, based on SDS-PAGE/immunoblots. Wild type and
mutant mitochondria contained similar amounts of CIII as revealed
by BN-PAGE of dodecylmaltoside dispersed mitoplasts. However, BN-
PAGE analyses of digitonin dispersed mitochondrial respirasomes
showeddecreased amounts of CIII dimers and CIII + IV supercomplexes,
but slightly compensatory increased levels of CI1III2IVn (n = number
of monomers) supercomplexes [75]. The overall data suggest that
supra-molecular interactions between the respiratory complexes are im-
portant for maintaining basal respiratory ETC function in the Y278Cmu-
tant. An emerging hypothesis from this ongoing work is that CIII activity
might be better protected against oxidative damages when the mutant
CIII is part of the CI1III2IVn supercomplexes (Fig. 3) [77]. Thus, compara-
tive studies conducted for the ﬁrst time with bacterial and human
mitochondrial CIII bearing the same homologous mutation (Y302C
and Y278C, respectively) suggest a new protective role for
supra-molecular organization of respiratory complexes in membranes.
4. Perspectives
Based on structural, biochemical and clinical studies, an integrated
model for ROS production in ETC, involving CI, CII and CIII complexes
with their higher order of organizations and physiological regulations
is emerging [54,78]. In the case of the Qo site of CIII, factors such as the
membrane potential, availability of oxidized and reduced equivalents
(Q and cytochrome c), redox state of the enzyme, and the presence of
critical amino acid residues located at speciﬁc locations, together
control the rate and the amount of ROS production. As described
here, recently initiated comparative studies of bacterial and human
mitochondrial CIII suggest a new role for supra-molecular organiza-
tions of the ETC complexes in membranes. Formation of respirasomes
appears to improve not only the substrate/product channeling be-
tween the related enzymes [79], but might also endow them with
higher degrees of stability and protection against oxidative damages
by restricting ROS generation (Fig. 3) [80].
Current challenges lay in the development of new tools to improve
speciﬁc detection and differentiation of various types of ROS free radi-
cals (e.g., O2•-, •OH, •H) at very low concentrations, especially when
using integrated systems like respirasomes, mitochondria or whole
cells, to better deﬁne their role(s) in both signal transduction and oxida-
tive stress. Undoubtedly, future studies will better address whether the
organization into larger macromolecular entities protects the structural
Fig. 3. Organization of ETC complexes into supercomplexes. A hypothetical higher level of organization of the respiratory complexes CI, CIII and CIV, modiﬁed from the recent
single-particle electron cryo-microscopy mediated structure (PDB 2YBB) of the supercomplex CI1CIII2CIV1 from bovine CIII and CIV and bacterial CI [77], is shown. The
higher-level structural organization into larger macromolecular entities is assumed to provide structural integrity to the individual ETC complexes by maximizing inter-complex
electron ﬂux, and minimizing possible oxidative damages associated with electron leakages. A plausible protective effect exerted at the Qo site of CIII via its close association
with CI is depicted for illustrative purposes. All of the other features shown are as described in the legend of Fig. 1.
1337P. Lanciano et al. / Biochimica et Biophysica Acta 1827 (2013) 1332–1339integrity of native andmutant ETC complexes, and minimizes oxidative
damages associated with electron leakages. Emerging investigations of
novel proteins promoting formation of supercomplexes [81–83], and
determination of ROS-mediated damages on surroundingphospholipids
promise to be very informative. The lipochaperone cardiolipin [84]
(and also ornithine lipid in somespecies [85]) is already implicated in af-
fecting the catalytic activity, formation, stability and reconstitution of
supra molecular organization of the ETC complexes [86]. Lipidomic
analyses usingmass spectrometry will allow accurate evaluation of sub-
tle changes in lipid proﬁles of intact mitochondria, isolated complexes
and supercomplexes [84]. Hopefully, these studies will merge together
to pave the way towards the development of novel and speciﬁc
therapeutic interventions for patients with mitochondrial CIII related
diseases.
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